Abstract

MG 50-3-1 (3, trisodium 1-amino-4-{4-[4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2-sulfophenylamino}-9,10-dioxo-9,10-dihydroanthracene 2-sulfonate) is the most potent and selective antagonist (IC50 4.6 nM) for “P2Y1-like” nucleotide-activated membrane receptors in guinea-pig taenia coli responsible for smooth muscle relaxation. Full characterization of the compound, however, e.g., at the human P2Y1 receptor, which is a novel potential target for antithrombotic drugs, as well as other P2 receptor subtypes, has been hampered due to difficulties in synthesizing the compound in sufficient quantity. MG 50-3-1 would be highly useful as a biological tool for detailed investigation of signal transduction in the gut. We have now developed a convenient, fast, mild, and efficient convergent synthesis of 3 based on retrosynthetic analysis. A new, regioselective Ullmann coupling reaction under microwave irradiation was successfully developed to obtain 1-amino-4-(4-amino-2-sulfophenylamino)-9,10-dioxo-9,10-dihydro­anthracene 2-sulfonate (8). Four different copper catalysts (Cu, CuCl, CuCl2, and CuSO4) were investigated at different pH values of sodium phosphate buffer, and in water in the absence or presence of base. Results showed that CuSO4 in water in the presence of triethylamine provided the best conditions for the regioselective Ullmann coupling reaction yielding the key intermediate compound 8. A new synthon (sodium 2-(4,6-dichloro-1,3,5-triazin-2-ylamino)benzenesulfonate, 13) which can easily be obtained on a gram scale was prepared, and 13 was successfully coupled with 8 yielding the target compound 3.

Highlights

  • Extracellular nucleotides such as ATP, ADP, UTP or UDP are the physiological ligands for P2 purinergic receptors, which are localized in the cell membrane [1,2,3,4]

  • Previous studies showed that the substitution pattern in the 4–position of the anthraquinone moiety plays a crucial role for the ability of the compounds to antagonize P2Y receptor subtypes, such as

  • The aqueous layer was reduced by rotary evaporation to ca. 20 mL, which was subsequently submitted to flash column chromatography (FCC) using RP-18 silica gel and water as an eluent

Read more

Summary

Introduction

Extracellular nucleotides such as ATP, ADP, UTP or UDP are the physiological ligands for P2 purinergic receptors, which are localized in the cell membrane [1,2,3,4]. They are subdivided into G protein-coupled or metabotropic P2Y receptors (GPCRs), and ligand-gated ion channels (LGICs) or ionotropic receptors, termed P2X. Both families, GPCRs as well as LGICs constitute important novel drug targets [1,2,3,4]. P2Y1 antagonists may have potential as novel antithrombotic drugs [6,7,13,14]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call